tetano
Editor, Senior Moderator
Clin Case Rep
. 2024 May 27;12(6):e8962.
doi: 10.1002/ccr3.8962. eCollection 2024 Jun. Long COVID-19 leading to Good's syndrome diagnosis: A clinical case-report and literature review
Payam Tabarsi[SUP] 1 [/SUP], Marjan Hemmatian[SUP] 2 [/SUP], Maryam Moradi[SUP] 3 [/SUP]
Affiliations
Key clinical message: Good's syndrome (GS) in conjunction with a severe COVID-19 infection, shedding light on the complexities of managing this rare condition that combines thymoma and immunodeficiency.
Abstract: This study delves into the clinical presentation and management of a 63-year-old male diagnosed with Good's syndrome (GS) amid a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. GS, an uncommon association between thymoma and immunodeficiency, remains a clinical mystery, necessitating increased awareness and understanding. Our patient's intricate clinical course, marked by recurrent COVID-19 symptoms and multiple hospitalizations, exemplifies the challenges posed by GS. Through a systematic review of GS cases globally, we highlight its worldwide distribution, with a substantial proportion reported in Europe. Notably, the diagnosis of thymoma often precedes immunodeficiency, emphasizing the importance of vigilance in clinical assessments.
Keywords: COVID‐19; Good's syndrome; SARS‐CoV‐2; long COVID‐19.
. 2024 May 27;12(6):e8962.
doi: 10.1002/ccr3.8962. eCollection 2024 Jun. Long COVID-19 leading to Good's syndrome diagnosis: A clinical case-report and literature review
Payam Tabarsi[SUP] 1 [/SUP], Marjan Hemmatian[SUP] 2 [/SUP], Maryam Moradi[SUP] 3 [/SUP]
Affiliations
- PMID: 38808198
- PMCID: PMC11130229
- DOI: 10.1002/ccr3.8962
Key clinical message: Good's syndrome (GS) in conjunction with a severe COVID-19 infection, shedding light on the complexities of managing this rare condition that combines thymoma and immunodeficiency.
Abstract: This study delves into the clinical presentation and management of a 63-year-old male diagnosed with Good's syndrome (GS) amid a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. GS, an uncommon association between thymoma and immunodeficiency, remains a clinical mystery, necessitating increased awareness and understanding. Our patient's intricate clinical course, marked by recurrent COVID-19 symptoms and multiple hospitalizations, exemplifies the challenges posed by GS. Through a systematic review of GS cases globally, we highlight its worldwide distribution, with a substantial proportion reported in Europe. Notably, the diagnosis of thymoma often precedes immunodeficiency, emphasizing the importance of vigilance in clinical assessments.
Keywords: COVID‐19; Good's syndrome; SARS‐CoV‐2; long COVID‐19.